Consequently, low and sub-physiological circulating IGF-1 levels are associated with an increased prevalence of CVD risk factors such as insulin resistance, hypertension, and with premature atherosclerosis, overt CVD and CVD-related and all-risk mortality [29, 31–34]. This evidence concerns the gene IGF1 and hypertensive disorder.